ProjectAMAL Therapeutics – HLA Ligands presented by Dendritic Cells

Basic data

Acronym:

AMAL Therapeutics

Title:

HLA Ligands presented by Dendritic Cells

Duration:

1/1/2016 to 12/31/2016

Abstract / short description:

Von Dendritischen Zellen (DC) werden über HLA-Immunpräzipitation und Ligandenextraktion Peptid charakterisiert, die aus Selbstproteinen und Tumorantigenen stammen.

Involved staff

Managers

Stevanovic, Stefan

Immunology
Interfaculty Institute for Cell Biology (IFIZ), Interfaculty Institutes

Local organizational units

Immunology

Interfaculty Institute for Cell Biology (IFIZ)
Interfaculty Institutes

Funders

Amal Therapeutics SA

Genf, Switzerland